Merck & Co. Inc. (NYSE:MRK) is one of the best low risk stocks to buy in 2026. On May 18, Merck announced that its pivotal ...

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds Merck & ...

Merck (NYSE:MRK) reported positive Phase 3 results for its antibody drug conjugate sacituzumab tirumotecan in advanced ...

All of them could be "forever" holdings, but the coming decade could prove surprisingly fruitful for each of these outfits.

AstraZeneca (AZN), and AbbVie (ABBV) are among the winners of positive drug recommendations in the EU this week. Read more ...

By Siddhi Mahatole May 21 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical said on Thursday its experimental treatment ...

New awareness initiative encourages people to look beyond blood pressure and better understand their heart health ...

EU CHMP recommends approval of Merck’s Keytruda plus Padcev as perioperative treatment for adults with cisplatin-ineligible resectable muscle-invasive bladder cancer: Rahway, Ne ...

The trial assesses Precem-TcT efficacy and safety alone or with bevacizumab in mCRC patients after previous therapies.

Shares of Merck & Co. (MRK) rose 5% on Friday after the pharmaceutical giant reported positive developments across multiple ...

Estee Lauder – The cosmetics company saw shares jump almost 10%. Estee Lauder and Puig confirmed on Thursday that they have ended talks about a potential merger. Workday — Workday shares jumped more ...

We expect that he will show up here,’ and other quotes of the week ...